BNGO · Bionano Genomics, Inc. · Exempt Offerings
$1.56
-0.17 (-9.83%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has prepared cash flows forecasts which indicate that based on the Company’s expected operating losses and negative cash flows, there is substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the six months ended June 30, 2026, are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$20.37M
Shares
11.78M
Volume · Sep 30
655.03K
Avg daily vol (3M)
910.17K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-07-10 | New | Biotechnology | $20,000,001 | $20,000,001 | 06b |
| 2024-06-05 | New | Biotechnology | $20,000,000 | $20,000,000 | 06b |
| 2023-10-27 | New | Other Health Care | $35,000,000 | $35,000,000 | 06b |
| 2021-10-25 | New | Other Health Care | $41,850,386 | $41,850,386 | 06b |
Showing 1–4 of 4 filings